Auris O Huen, MD, PharmD
Department of Dermatology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2011 | The University of Texas Medical Branch, Galveston, TX, USA, MD, Doctor of Medicine |
| 1999 | The University of Texas at Austin, Austin, TX, USA, PHARMD, Doctor of Pharmacy |
Postgraduate Training
| 2012-2015 | Residency in Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA |
| 2011-2012 | Internship in Medicine, Baylor College of Medicine, Houston, TX |
| 2000-2001 | Residency in Oncolog Pharmacy, University of Texas M.D. Anderson Cancer Center, Houston, TX |
| 1999-2000 | Residency in Clinical Pharmacy Practice, University of California, San Francisco, CA |
Board Certifications
| 2015 | American Board of Dermatology: Board Certified Dermatologist |
Honors & Awards
| 2021 | Excellence in Patient Care, Division of Internal Medicine |
| 2010 | Alpha Omega Alpha Honor Medical Society - Junior Inductee, Alpha Omega Alpha Honor Medical Society |
| 1996 | Rho Chi Pharmaceutical Honor Society-Elected Member |
Selected Publications
Peer-Reviewed Articles
- Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?. Virchows Arch 479(2):377-383, 2021. e-Pub 2021. PMID: 33604757.
- Torres-Cabala CA, Huen A, Iyer SP, Miranda RN. Gamma/Delta Phenotype in Primary Cutaneous T-cell Lymphomas and Lymphoid Proliferations: Challenges for Diagnosis and Classification. Surg Pathol Clin 14(2):177-194, 2021. e-Pub 2021. PMID: 34023099.
- Porcu P, Hudgens S, Horwitz S, Quaglino P, Cowan R, Geskin L, Beylot-Barry M, Floden L, Bagot M, Tsianakas A, Moskowitz A, Huen A, Dreno B, Dalle S, Caballero D, Leoni M, Dale S, Herr F, Duvic M. Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. Clin Lymphoma Myeloma Leuk 21(2):97-105, 2021. e-Pub 2020. PMID: 33158772.
- Messer A, Brown AE, Pacha O, Boddu P, Geppner A, Kadia TM, Huen AO. Successful treatment of cutaneous adult T-cell leukemia/lymphoma with imiquimod. JAAD Case Rep 5(11):979-981, 2019. e-Pub 2019. PMID: 31709290.
- Aria AB, Chen L, Huen AO. A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report. SAGE Open Med Case Rep 6:2050313X18795075, 2018. e-Pub 2018. PMID: 30214807.
- Emge DA, Bassett RL, Duvic M, Huen AO. Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients. Arch Dermatol Res. e-Pub 2019. PMID: 31776647.
Editorials
- Huen AO, Rook AH. Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma. Curr Opin Oncol 26(2):237-44, 2014. PMID: 24441505.
Abstracts
- Huen AO, Rahbar Z, Talpur R, Li S, Hong EE, Tetzlaff M, Duvic M, Kim YH. Updated Combined Analysis of Two Phase II Studies of Brentuximab Vedotin in Patients with Mycosis Fungoides and Sezary Syndrome. EORTC St. Galen, Switzerland, 2018.
- Huen A, Zain J, Querfeld C, Haverkos B, Barole P, Kavandar M, Duvic M, Penmetsa K, Oki Y.. Evaluation of RP6530, a Novel dual PI3K δ/γ inhibitor in patients with relaxed/refractory T-Cell Lymphoma. T-Cell Lymphoma Forum. January 2017, San Francisco, CA, 2017.
- Oki Y, Huen AO, Barde P; Penmetsa K; Ashu AJ, Wilson C, Pullokaran L, Viswanadha S; Duvic M.. A dose escalation study of RP6530, a novel dual PI3K δ/γ inhibitor, in patients with relapsed/refractory t-cell lymphoma. American Society of Mematology Annual Meeting . December 2016, San Diego, CA, 2016.
- Pickett MM, Sapority RC, Nagarajan P, Huen AO,. EBV-positive lymphoproliferative disorder presenting as a hypersensitivity reaction. Texas Dermatological Society Annual Meeting, September 2016, 2016.
- Huen A, DeAngelo D, Fanale M, Vadhan-Raj S. Pharmacokinetic analysis of two dose levels of rasburicase in adult patients with hermatologic malignancies at high or potential risk for tumor lysis syndrome. J Clin Oncol 26(15S), 2008.
- Zhou X, Huen A, Teegala S, Ji Y, Fayad LE, Hagemeister FB, Vadhan-Raj S. Incidence and significant predicting factors for chemotherapy-induced severe thrombocytopenia in lymphoma patients. J Clin Oncol 26(15S), 2008.
- Teegala SR, Zhou X, Huen A, Ji Y, Fayad LE, Romaguera JE, Vadham-Raf S.. Risk Factors for neutropenic fever in lymphoma patients receiving chemotherapy. J Clin Oncol 25(185), 2007.
- Zhou X, Teegala S, Huen A, Ji Y, Fayad LE, Romaguera JE, Hagmeister FB, Vadhan-Raj S.. Risk factors for severe anemia requiring red blood cell transfusions in lymphoma patients receiving chemotherapy. J Clin Oncol 25(185), 2007.
- Thompson MA, Huen A, Toth BB, Vassilopoulou-Sellin R, Hoff, AO, Murphy WA, Sanjorjo H, Bekele BN, Arbuckle RB, Hagemeister FB. Osteopenia and osteoporosis in untreated non-Hodgkin's lymphoma patients: An important and potentially treatable survivorship issue in lymphoma. J. Clin Oncol 25(185), 2007.
- Hicks K, Hachem R.Y., Huen A, Raad II. Myelosuppression and serotonin syndrome associated with linezolid and selective serotonin re-uptake inhibitors (SSRIs). Annual Meeting of the infectious Diseases Society of America. San Francisco. CA, 2001.
Book Chapters
- Huen A.. Cutaneous Lymphoma. In: The MD Anderson Manual of Medical Oncology.